303 related articles for article (PubMed ID: 12534601)
1. Melanocyte detachment after skin friction in non lesional skin of patients with generalized vitiligo.
Gauthier Y; Cario-Andre M; Lepreux S; Pain C; Taïeb A
Br J Dermatol; 2003 Jan; 148(1):95-101. PubMed ID: 12534601
[TBL] [Abstract][Full Text] [Related]
2. The melanocytorrhagic hypothesis of vitiligo tested on pigmented, stressed, reconstructed epidermis.
Cario-André M; Pain C; Gauthier Y; Taïeb A
Pigment Cell Res; 2007 Oct; 20(5):385-93. PubMed ID: 17850512
[TBL] [Abstract][Full Text] [Related]
3. Type-1 cytokines regulate MMP-9 production and E-cadherin disruption to promote melanocyte loss in vitiligo.
Boukhedouni N; Martins C; Darrigade AS; Drullion C; Rambert J; Barrault C; Garnier J; Jacquemin C; Thiolat D; Lucchese F; Morel F; Ezzedine K; Taieb A; Bernard FX; Seneschal J; Boniface K
JCI Insight; 2020 Jun; 5(11):. PubMed ID: 32369451
[TBL] [Abstract][Full Text] [Related]
4. Altered E-Cadherin Levels and Distribution in Melanocytes Precede Clinical Manifestations of Vitiligo.
Wagner RY; Luciani F; Cario-André M; Rubod A; Petit V; Benzekri L; Ezzedine K; Lepreux S; Steingrimsson E; Taieb A; Gauthier Y; Larue L; Delmas V
J Invest Dermatol; 2015 Jul; 135(7):1810-1819. PubMed ID: 25634357
[TBL] [Abstract][Full Text] [Related]
5. Discoidin domain receptor-1 as a player in impairment of melanocytes adhesion process in vitiligo.
Elgarhy LH; Abdullatif A; Abdelazim R; El-Desouky KI
G Ital Dermatol Venereol; 2016 Oct; 151(5):473-9. PubMed ID: 26091274
[TBL] [Abstract][Full Text] [Related]
6. Effect of PUVA therapy on melanocytes and keratinocytes in non-segmental vitiligo: histopathological, immuno-histochemical and ultrastructural study.
Anbar TS; El-Sawy AE; Attia SK; Barakat MT; Moftah NH; El-Ammawy TS; Abdel-Rahman AT; El-Tonsy MH
Photodermatol Photoimmunol Photomed; 2012 Feb; 28(1):17-25. PubMed ID: 22211999
[TBL] [Abstract][Full Text] [Related]
7. Tenascin is overexpressed in vitiligo lesional skin and inhibits melanocyte adhesion.
Le Poole IC; van den Wijngaard RM; Westerhof W; Das PK
Br J Dermatol; 1997 Aug; 137(2):171-8. PubMed ID: 9292062
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients.
van den Boorn JG; Konijnenberg D; Dellemijn TA; van der Veen JP; Bos JD; Melief CJ; Vyth-Dreese FA; Luiten RM
J Invest Dermatol; 2009 Sep; 129(9):2220-32. PubMed ID: 19242513
[TBL] [Abstract][Full Text] [Related]
9. Melanocytes are not absent in lesional skin of long duration vitiligo.
Tobin DJ; Swanson NN; Pittelkow MR; Peters EM; Schallreuter KU
J Pathol; 2000 Aug; 191(4):407-16. PubMed ID: 10918216
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical analysis of melanocyte content in different zones of vitiligo lesions using the Melan-A marker.
Kubanov A; Proshutinskaia D; Volnukhin V; Katunina O; Abramova T
Acta Dermatovenerol Alp Pannonica Adriat; 2016; 25(1):5-9. PubMed ID: 27014772
[TBL] [Abstract][Full Text] [Related]
11. Vitiligo - The story from within: A transmission electron microscopic study before and after narrow-band ultraviolet B.
Fawzy MM; El Maadawi ZM; Hegazy RA; El Fatah NS
Ultrastruct Pathol; 2016; 40(5):265-75. PubMed ID: 27594347
[TBL] [Abstract][Full Text] [Related]
12. Ultrastructural study of vitiligo.
Galadari E; Mehregan AH; Hashimoto K
Int J Dermatol; 1993 Apr; 32(4):269-71. PubMed ID: 8486458
[TBL] [Abstract][Full Text] [Related]
13. Possible patterns of epidermal melanocyte disappearance in nonsegmental vitiligo: a clinicopathological study.
Benzekri L; Hmamouchi I; Gauthier Y
Br J Dermatol; 2015 Feb; 172(2):331-6. PubMed ID: 24902987
[TBL] [Abstract][Full Text] [Related]
14. Melanocytorrhagy and apoptosis in vitiligo: connecting jigsaw pieces.
Kumar R; Parsad D
Indian J Dermatol Venereol Leprol; 2012; 78(1):19-23. PubMed ID: 22199056
[TBL] [Abstract][Full Text] [Related]
15. Aberrant ETS-1 signalling impedes the expression of cell adhesion molecules and matrix metalloproteinases in non-segmental vitiligo.
Srivastava N; Bishnoi A; Mehta S; Rani S; Kumar R; Bhardwaj S; Sendhil Kumaran M; Keshavamurthy V; Gupta S; Parsad D
Exp Dermatol; 2020 Jun; 29(6):539-547. PubMed ID: 32350934
[TBL] [Abstract][Full Text] [Related]
16. Immunolocalization of tenascin-C in vitiligo.
Abdou AG; Maraee AH; Shoeib MA; Elbana R
Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):501-11. PubMed ID: 22495383
[TBL] [Abstract][Full Text] [Related]
17. Melanocyte Adhesion and Apoptosis in Vitiligo: Linking Puzzle Blocks.
Srivastava N; Gupta S; Parsad D
Curr Mol Med; 2023; 23(8):709-711. PubMed ID: 35726816
[TBL] [Abstract][Full Text] [Related]
18. Molecular and cellular basis of depigmentation in vitiligo patients.
Delmas V; Larue L
Exp Dermatol; 2019 Jun; 28(6):662-666. PubMed ID: 30536790
[TBL] [Abstract][Full Text] [Related]
19. Ultrastructural and functional alterations of mitochondria in perilesional vitiligo skin.
Prignano F; Pescitelli L; Becatti M; Di Gennaro P; Fiorillo C; Taddei N; Lotti T
J Dermatol Sci; 2009 Jun; 54(3):157-67. PubMed ID: 19282153
[TBL] [Abstract][Full Text] [Related]
20. Glabrous lesional stem cells differentiated into functional melanocytes: new hope for repigmentation.
Kumar R; Parsad D; Rani S; Bhardwaj S; Srivastav N
J Eur Acad Dermatol Venereol; 2016 Sep; 30(9):1555-60. PubMed ID: 27538731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
